
IRWD Technical Analysis Summary (NASDAQ)
Analyze IRWD on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerIRWD Technical Analysis Summary (NASDAQ)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Ironwood Pharmaceuticals, Inc. on the NASDAQ is awaiting a decisive move. This mix signals that Ironwood Pharmaceuticals, Inc. is trading in a balanced range with no clear breakout yet.
RSI (14): 56.21
Stochastic %K: 64.74
Williams %R: -25.96
Rate of Change (ROC): 13.98
Takeaway:Ironwood Pharmaceuticals, Inc. shows strong bullish momentum, with buyers firmly in control.
MACD: 0.08
ADX: 15.34
ATR (14): 0.27
CCI (14): 79.39
Takeaway:Ironwood Pharmaceuticals, Inc. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Ironwood Pharmaceuticals, Inc. trades closer to resistance, supported by stronger momentum within bands.
Takeaway:Ironwood Pharmaceuticals, Inc. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:IRWD shows mixed signals in money flow analysis.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
No significant bearish signals detected.
Overall Recommendation:Technical indicators for Ironwood Pharmaceuticals, Inc. are mixed, suggesting a Hold or wait-and-see approach.